drugset / Trial / NCT04294953

Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery

NCT04294953

Phase 2 Unknown 60 enrolled Assiut University
RandomizedParallel-groupTriple-blindPrevention

Summary

Our aim will be to evaluate the efficacy of perioperative Duloxetine in decreasing acute postoperative pain after laparoscopic colorectal cancer surgery and its role in reducing postoperative morphine requirements

Timeline

Start
2020-03-01
Primary completion
2021-03-01
Completion
2021-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 60 mg Oral

Indications